Drugs

We continually prove it’s possible to invent and advance affordable and effective medicines that prevent and treat diseases of poverty, like HIV, malaria, diarrheal disease, and infections—and to get them safely to people who need them.

Our Work
35 Articles
35 Articles
35 Articles
  1. Pauline Irungu speaks at PATH session on regulatory harmonisation at AHAIC in March 2019
    March 26, 2019

    "Patients are waiting." Aligning regulation of medical products across Africa to unleash innovation

    Research and development (R&D) into new medical products is the engine driving progress toward health for all. Regulatory approvals are essential to ensuring the safety and efficacy of these products—but regulatory processes differ from country to country across Africa, resulting in delays in introduction and scale-up.

  2. Cryptosporidium
    December 31, 2018

    Combining forces to alleviate the burden of Cryptosporidium

    Diarrhea is more than just unpleasant. It’s deadly.

  3. Good gut health is key to optimal growth and development. Without it, children can develop environmental enteric dysfunction, which can result in chronic malnutrition and stunting. Image: PATH.
    December 11, 2018

    Addressing the hidden burden of gut dysfunction

    It doesn’t have any overt symptoms, but around the world, environmental enteric dysfunction (EED) causes lifelong harm to the most vulnerable children.

  4. Diarrheal disease, Cryptosporidium  - cBangladesh cholera clinic - photo Jonathan Torgovnik©, Drug Dev program, use with permission only
    December 1, 2018

    Cryptosporidium: time to “decrypt” a wily parasite

    A lot of ugly things in nature are relatively harmless (Exhibit A: the star-nosed mole)—but Cryptosporidium isn’t one of them.

  5. Woman holds subcutaneous DMPA (DMPA-SC, Sayana Press)
    September 12, 2018

    The power to prevent pregnancy in women’s hands: DMPA-SC injectable contraception

    Women want and need access to a variety of contraceptives to plan, space, and prevent pregnancies. PATH is expanding access and options with DMPA-SC (brand name Sayana® Press), an all-in-one contraceptive that puts women in charge of their reproductive health.

  6. Blue PATH String
    July 31, 2018

    The global health world is changing, and so are we: PATH's CEO on our next 40 years

    The world has changed in remarkable—even unprecedented—ways since PATH got its start. Now we're accelerating our efforts to create greater health, equity, and opportunity everywhere.

Load more